Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment

NCT00691808 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-Related Memory Disorders

Interventions

DRUG: LX6171 High Dose
DRUG: LX6171 Low Dose
DRUG: Placebo

Sponsor

Lexicon Pharmaceuticals